Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
The purpose of this study is to assess the cross-sectional prevalence of the metabolic
 syndrome in patients with schizophrenia taking antipsychotics.
Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul
 National Hospital will be participated in this study.

 we are planning to enroll approximately 1000 patients with schizophrenia.

 For each subject

 -  abdominal circumference

 -  body mass index

 -  lipid profile : TG, HDL-chlo, total chol

 -  systolic/diastolic blood pressure

 -  fasting blood glucose will be measured.

 we will calculate the rates of patients who meet the criteria for the Metabolic syndrome.

 1. Abdominal obesity : absolute criteria

 2. 2 or more of followings

 1. Triglyceride ≥ 150mg/dL or ongoing treatment

 2. HDL-cholesterol < 40mg/dL (men) HDL-cholesterol < 50mg/dL (female) or ongoing
 treatment

 3. Hypertension 130mmHg ≥ systolic 85mmHg ≥ diastolic or ongoing treatment

 4. FBS ≥ 100mg/dL or previous diagnosis of type II DM
Inclusion Criteria:

 -  Patients taking a same antipsychotics at least more than one year

 -  schizophrenia or schizoaffective disorder

 Exclusion Criteria:

 -  none